Ductaclose 1mg Injection helps in relieving moderate pain and reducing fever. It effectively alleviates pain and inflammation in conditions like rheumatoid arthritis, osteoarthritis, gout, and ankylosing spondylitis. It is given in cases where oral administration is not possible.
Ductaclose 1mg Injection is administered as an injection by a healthcare professional. Kindly do not self-administer. Inform your doctor if you have any history of heart disease or stroke. Please consult your doctor in case any injection site reactions like pain, swelling, or redness are observed.
Some of the common side effects of this medicine include injection site reactions, bleeding dosorder, vomiting, stomach pain, and nausea. It may also cause dizziness, drowsiness, or visual disturbances. Your doctor may regularly monitor your kidney function, liver function, and levels of blood components if you are taking this medicine for long-term treatment. Long-term use may lead to serious complications such as stomach bleeding and kidney problems.
Ductaclose 1mg Injection belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis.
Take it as it is prescribed to get the most benefit. Do not take more or for longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
Side effects of Ductaclose Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Ductaclose
Injection site reactions (pain, swelling, redness)
Vomiting
Nausea
Dizziness
Visual disorder
Drowsiness
Bleeding disorder
Increased creatinine level in blood
How to use Ductaclose Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Ductaclose Injection works
Ductaclose 1mg Injection is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Ductaclose 1mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Ductaclose 1mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Ductaclose 1mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Ductaclose 1mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Ductaclose 1mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Ductaclose 1mg Injection may be needed. Please consult your doctor. Regular monitoring of kidney function test and potassium levels is advised while you are taking this medicine.
Liver
CAUTION
Ductaclose 1mg Injection should be used with caution in patients with liver disease. Dose adjustment of Ductaclose 1mg Injection may be needed. Please consult your doctor.
What if you forget to take Ductaclose Injection?
If you miss a dose of Ductaclose 1mg Injection, consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
You have been prescribed Ductaclose 1mg Injection to relieve pain and inflammation.
Take it as per the dose and duration prescribed by your doctor. Long term use may lead to serious complications such as stomach bleeding and kidney problems.
It may cause dizziness, drowsiness or visual disturbances. Use caution while driving or doing anything that requires concentration.
Avoid consuming alcohol while taking Ductaclose 1mg Injection as it can cause excessive drowsiness and increase your risk of stomach problems.
Inform your doctor if you have a history of heart disease or stroke.
Your doctor may regularly monitor your kidney function, liver function and levels of blood components, if you are taking this medicine for long-term treatment.
I am suffering from chikungunya since last 2 days I m experiencing high fever and too much pain in my body Plzz suggest me about HOW TO NEUTRALIZE THE PAIN IN THE BODY
Is Ductaclose 1mg Injection an antibiotic or steroid?
No, Ductaclose 1mg Injection is neither an antibiotic nor a steroid. It belongs to the non-steroidal anti-inflammatory drugs (NSAIDs) group of medicines. It is used to relieve moderate to severe pain and inflammation.
How should Ductaclose 1mg Injection be administered?
Ductaclose 1mg Injection injection should only be given by a healthcare professional. It can be given deep into the muscle (intramuscularly), preferably in the buttock, under the skin (subcutaneously), or directly into a vein (intravenously) as a bolus and not an infusion. The dose will depend on the condition you are being treated for and will be decided by your doctor. Follow your doctor’s instructions carefully to get maximum benefit from Ductaclose 1mg Injection.
Is Ductaclose 1mg Injection a good painkiller?
Ductaclose 1mg Injection is effective in relieving pain and inflammation. It is used to provide relief from various sorts of pain, such as sprains, strains, and other injuries. It is also helpful in the treatment of different types of arthritis and gout. Along with that, it can be used to reduce pain and inflammation which follow after surgery.
Is Ductaclose 1mg Injection safe?
Ductaclose 1mg Injection is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.
What are the side effects of Ductaclose 1mg Injection?
Some common side effects associated with Ductaclose 1mg Injection include vomiting, stomach pain, nausea, and indigestion. It may also cause dizziness, drowsiness, or visual disturbances. However, these side effects are usually not bothersome and resolve in some time. If they persist for a longer duration or worry you, consult your doctor.
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
References
Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 627.
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 984-85.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 707-712.